ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,360.79
      0.26%
      US Tech 100
      18,564.00
      0.25%
      Dow Jones
      38,868.04
      0.18%
      Brent Oil
      81.335
      -0.54%
      Bitcoin
      67,888.00
      -2.33%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Curagen Corp. (MM) (CRGN)

      7. Curagen Corp. (MM) (CRGN) News

      CRGN

      Curagen Corp. (MM) (CRGN)

      Curagen Corp. (MM)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:CRGN
      DateTimeSourceHeadlineSymbolCompany
      10/02/20096:02AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      10/01/20094:28PMEdgar (US Regulatory)(25-NSE)NASDAQ:CRGNCuragen Corp. (MM)
      10/01/20092:29PMBusiness WireCelldex Therapeutics Announces Completed Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
      09/30/20096:00PMBusiness WireCelldex and CuraGen Stockholders Approve Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
      09/25/20094:33PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
      09/25/20091:33PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      09/03/20096:01AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
      08/28/20095:27PMEdgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (DEFM14A)NASDAQ:CRGNCuragen Corp. (MM)
      08/17/20094:50PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:CRGNCuragen Corp. (MM)
      08/10/200911:59AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRGNCuragen Corp. (MM)
      08/05/20092:03PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CRGNCuragen Corp. (MM)
      07/31/20092:35PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      07/31/20092:33PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
      07/31/20096:00AMPR Newswire (US)CuraGen Reports Second Quarter 2009 Financial ResultsNASDAQ:CRGN
      06/22/20095:07PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:CRGNCuragen Corp. (MM)
      06/19/20091:45PMEdgar (US Regulatory)Amended Annual Report (10-K/A)NASDAQ:CRGNCuragen Corp. (MM)
      06/18/20091:43PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      06/17/20096:30AMPR Newswire (US)CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast CancerNASDAQ:CRGNCuragen Corp. (MM)
      06/10/20095:02PMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CRGNCuragen Corp. (MM)
      06/09/20093:22PMEdgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:CRGNCuragen Corp. (MM)
      06/03/20093:42PMEdgar (US Regulatory)Amended Current report filing (8-K/A)NASDAQ:CRGNCuragen Corp. (MM)
      06/02/20096:30AMPR Newswire (US)CuraGen Updates CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
      05/29/20095:26PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      05/29/20095:24PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
      05/29/20094:50PMEdgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:CRGNCuragen Corp. (MM)
      05/29/20094:35PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:CRGNCuragen Corp. (MM)
      05/29/20094:33PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CRGNCuragen Corp. (MM)
      05/29/20096:54AMBusiness WireCelldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen CorporationNASDAQ:CRGNCuragen Corp. (MM)
      05/28/20096:30AMPR Newswire (US)CuraGen to Present CR011-vcMMAE Data at ASCONASDAQ:CRGNCuragen Corp. (MM)
      05/19/20093:15PMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CRGNCuragen Corp. (MM)
       Showing the most relevant articles for your search:NASDAQ:CRGN